Inventor · disambiguated record
Matthew Vincent
Also filed as: VINCENT MATTHEW · VINCENT MATTHEW P
4 granted patents·14 pending applications·0 citations·filing 2012–2025
55Inventor score
Files withUNIV HOUSTON SYSTEM9AVACTA LIFE SCIENCES LTD4XIAN WA2AGENCY FOR SCIENCE TECH AND RESEARCH ASTARSTAR1TUFTS COLLEGE1
Top patents by PatentIndex Score
18 records- 0175US12351822B2Stem cell culture systems for columnar epithelial stem cells, and uses related theretoUNIV HOUSTON SYSTEM·Filed 2023·Granted Jul 8, 2025·0 cites·12 claims
- 0265US2023233691A1Methods and compositions for treating chronic inflammatory injury, metaplasia, dysplasia and cancers of epithelial tissuesUNIV HOUSTON SYSTEM·Filed 2022·Application pending·0 cites
- 0363US2025281624A1Methods and compositions for treating chronic inflammatory injury, metaplasia, dysplasia and cancers of epithelial tissuesUNIV HOUSTON SYSTEM·Filed 2025·Application pending·0 cites
- 0462US11725185B2Stem cell culture systems for columnar epithelial stem cells, and uses related theretoUNIV HOUSTON SYSTEM·Filed 2018·Granted Aug 15, 2023·0 cites·10 claims
- 0553US2021401987A1Methods and compositions for treating inflammatory and fibrotic pulmonary disordersUNIV HOUSTON SYSTEM·Filed 2021·Application pending·0 cites
- 0652US2024158756A1Feeder-based and feeder-free stem cell culture systems for stratified epithelial stem cells, and uses related theretoUNIV HOUSTON SYSTEM·Filed 2020·Application pending·0 cites
- 0750US2023149295A1Inflammatory bowel disease stem cells, agents which target ibd stem cells, and uses related theretoUNIV HOUSTON SYSTEM·Filed 2021·Application pending·0 cites
- 0848US12208287B2Inflammatory bowel disease stem cells, agents which target IBD stem cells, and uses related theretoUNIV HOUSTON SYSTEM·Filed 2018·Granted Jan 28, 2025·0 cites·4 claims
- 0947US2023390409A1Fap-activated serum extended half-life therapeutic conjugatesAVACTA LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 1047US2022202792A1Methods and compositions for treating chronic inflammatory injury, metaplasia, dysplasia and cancers of epithelial tissuesUNIV HOUSTON SYSTEM·Filed 2020·Application pending·0 cites
- 1147US2023381330A1Enzyme-activated serum extended half-life therapeutic conjugatesAVACTA LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 1247US2021353652A1Tumor microenvironment-activated drug-binder conjugates, and uses related theretoTUFTS COLLEGE·Filed 2019·Application pending·0 cites
- 1344US9950032B2Compositions and methods for lung regenerationAGENCY FOR SCIENCE TECH AND RESEARCH ASTARSTAR·Filed 2012·Granted Apr 24, 2018·0 cites·6 claims
- 1443US2023272081A1Serum half-life extended pd-l1 inhibitory polypeptidesAVACTA LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 1542US2014255430A1Methods and reagents for detection and treatment of esophageal metaplasiaUNIV SINGAPORE·Filed 2013·Application pending·0 cites
- 1641US2019358292A1Compositions and methods for lung regenerationXIAN WA·Filed 2018·Application pending·0 cites
- 1741US2015044135A1Dual function markers for diagnostics and therapeutics for upper gastrointestinal tract precancerXIAN WA·Filed 2014·Application pending·0 cites
- 1841US2023272011A1Serum albumin-binding polypeptidesAVACTA LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Vincent files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →